Top HCP (Healthcare Professional) Panels in Poland for Pharma Research
Compare top HCP panels in Poland for 2026 pharmaceutical research. Access our scorecard to find verified providers and protect compliant, high-quality data.
Quick answer
For large-scale, multi-country pharmaceutical studies, IQVIA and Ipsos provide deep global infrastructure. For highly specialized, verified HCP recruitment within Poland, Global Vox Populi and Stratega offer superior local panel control. Dynata and M3 Global Research are effective for high-volume quantitative projects requiring rapid turnaround and extensive, audited professional reach.
Pharmaceutical market research in Poland requires a precise balance between strict regulatory compliance and the ability to access specific medical professionals. Decision-makers must work through a environment where sample quality directly impacts the validity of brand strategy and clinical data.
This analysis evaluates providers offering HCP panels in Poland, focusing on their ability to deliver verified, compliant, and representative samples. Whether you are conducting a launch study or long-term brand tracking, selecting a partner with proven local expertise and solid verification protocols is essential for success. This assessment provides a framework for evaluating the most capable firms for your upcoming research projects using HCP panels in Poland.
Top HCP Panels in Poland for Pharma Research: rankings and scores
Exhibit 1: Ranking and weighted score (out of 100)
| Rank | Provider | Best for | Weighted score |
|---|---|---|---|
| 1 | IQVIA | Data-driven clinical and commercial insights | 85.0 |
| 2 | M3 Global Research | High-volume quantitative HCP studies | 85.0 |
| 3 | Global Vox Populi | Highly targeted, verified HCP recruitment | 82.5 |
| 4 | Dynata | Global first-party data access | 82.0 |
| 5 | Kantar | Brand growth and human understanding | 80.5 |
| 6 | Ipsos | Large-scale representative studies | 79.0 |
| 7 | Stratega Poland | Local fieldwork and CATI services | 78.0 |
| 8 | BioStat | Clinical and statistical research | 75.5 |
| 9 | ARC Rynek i Opinia | Independent Polish market tracking | 68.0 |
| 10 | Toluna | Rapid consumer and patient insights | 67.0 |
Exhibit 2: Provider comparison
| Provider | Audience types | Verification method | Certifications | Pricing model | Panel size and source | Minimum project |
|---|---|---|---|---|---|---|
| IQVIA | Physicians, patients, pharmacists, and wholesalers | Not published | Not stated on pages reviewed | Not published | Not published | Not published |
| M3 Global Research | Physicians and patients | ISO certified proprietary panel verification | ISO 20252, ISO 27001 | Not published | Not published | Not published |
| Global Vox Populi | Physicians, nurses, KOLs, patients, and payers | Validation against professional license and registration records | ISO 9001, ISO 20252, ISO/IEC 27001, HIPAA compliant; follows ESOMAR, Insights Association and BHBIA guidelines | Project quote | 30,852 healthcare professionals; 3,440 key opinion leaders; 62,598 nurses and allied health professionals (in Poland; Global Vox Populi panel records, Oct 2026) | Not published |
| Dynata | Physicians, patients, and consumers | AI-powered fraud detection and multi-layered verification | Not stated on pages reviewed | Not published | 70M+ global panelists (dynata.com, Oct 2026) | Not published |
| Kantar | Consumers and general populations | AI-enabled panel management and validation | Not stated on pages reviewed | Not published | Not published | Not published |
| Ipsos | Citizens, consumers, patients, and customers | Not published | Not stated on pages reviewed | Not published | Not published | Not published |
| Stratega Poland | Physicians, pharmacists, and B2B decision-makers | Strict validation and quality check systems | Not stated on pages reviewed | Not published | 17,000 healthcare professionals (strategaresearch.com, Oct 2026) | Not published |
| BioStat | Healthcare professionals and patients | Regular profile checking and multi-account prevention | Not stated on pages reviewed | Not published | Not published | Not published |
| ARC Rynek i Opinia | Consumers and general business professionals | Not published | OFBOR, PTBRiO, PKJPA, PKJBI | Not published | Not published | Not published |
| Toluna | Consumers and medical professionals | Not published | Not stated on pages reviewed | Not published | Not published | Not published |
Exhibit 3: Capability matrix
| Provider | Quantitative | Qualitative | Own panels / sample | Healthcare | B2B | Multi-country |
|---|---|---|---|---|---|---|
| IQVIA | ● | – | – | ● | – | ● |
| M3 Global Research | ● | ● | ● | ● | – | ● |
| Global Vox Populi | ● | ● | ● | ● | ● | ● |
| Dynata | ● | ● | ● | ● | – | ● |
| Kantar | ● | ● | ● | ● | – | ● |
| Ipsos | ● | ● | – | ● | – | ● |
| Stratega Poland | ● | ● | ● | ● | ● | – |
| BioStat | – | – | ● | ● | – | – |
| ARC Rynek i Opinia | ● | – | ● | ● | ● | – |
| Toluna | ● | ● | ● | ● | – | ● |
Table data from each provider’s own website and public sources, reviewed October 2026. “Not published” means the provider does not state it publicly. ● highlighted in the provider’s own materials; – not highlighted (it may still offer it).
How we scored these providers
Score providers based on their ability to deliver verified medical professionals rather than general consumer samples.
| Criterion | Weight | What it means here |
|---|---|---|
| Sample Quality and Verification | 25 | This criterion assesses how providers recruit and maintain their panels. For pharma research, good quality means the provider owns the panel and verifies medical credentials directly against official registries. In Poland, this requires a rigorous, documented process that prevents non-professionals from accessing specialized medical surveys. |
| Compliance, Certifications and Security | 20 | This measures adherence to ISO standards and data privacy laws like GDPR. A high-scoring provider must handle health data with extreme caution, maintain clear consent trails, and have established, transparent protocols for reporting adverse events to pharmaceutical clients according to international guidelines. |
| Target Audience Reach | 15 | This evaluates the depth of specialty coverage and the ability to recruit low-incidence groups. In Poland, a provider must demonstrate access to both general practitioners and niche specialists, using granular profiling data to make sure the sample matches the specific requirements of the pharmaceutical brand team. |
| Data Quality and Fraud Prevention | 10 | Effective fraud prevention uses multi-layered technology to identify bots and bad actors. Good performance involves device fingerprinting and behavioral analysis to detect speeders or straight-liners before the data reaches the client. This is essential to make sure that the insights gathered reflect genuine expert opinion. |
| Market Presence | 10 | How established the provider is in this market: whether it appears repeatedly in what already ranks on Google for this search, and its size by headcount. Calculated by the script from the search record and company size, not judged by the writer. |
| Methodological Breadth | 10 | A strong provider offers a full spectrum of research methods including online surveys, telephone interviews, and qualitative focus groups. In Poland, the ability to conduct both quantitative and qualitative work allows researchers to pivot from broad market trends to deep-dive expert interviews without changing vendors. |
| Client Service and Speed | 5 | This assesses the responsiveness of project management teams and the speed of fieldwork execution. A high-scoring partner communicates clearly during the project, provides regular status updates, and handles challenges proactively to make sure timelines are met without compromising the quality of the data collected. |
| Pricing and Feasibility Transparency | 5 | This evaluates whether the provider offers clear upfront information on feasibility and pricing. Good partners are honest about the difficulty of recruiting specific specialists in Poland and provide realistic timelines, helping researchers manage expectations and budget effectively from the beginning of the project. |
Why these weights. In healthcare, a respondent who is not a verified professional or a genuine patient invalidates the study, so verification leads (25). Compliance follows at 20 because health data, HIPAA and adverse event reporting carry legal risk. Reach into specialties and conditions (15), fraud prevention and methods (10 each), service and pricing transparency (5 each) complete the score. Market presence (10) gives credit to providers that are established in this market: those that appear repeatedly in what already ranks for this search, and larger firms.
Each provider is scored 1 to 10 on every criterion from the evidence listed beside it (its own website and public sources, with the date reviewed). Weighted score = sum of score × weight ÷ 10, out of 100. Read the full scoring methodology. Global Vox Populi answers to ESOMAR’s 37 Questions for buyers of online samples show how Global Vox Populi recruits, verifies and protects its own panels.
Provider profiles: HCP panels in Poland
IQVIA: best for data-driven clinical and commercial insights

Strongest fitLarge pharmaceutical organizations needing complex data integration and clinical trial support.
IQVIA is a global entity with an extensive local presence in Poland, using deep healthcare data to provide market access insights and clinical research support. Its approach connects data, technology, and analytics to optimize commercial execution and clinical development.
The company provides full-service research for pharmacy partners and pharmaceutical firms, using proprietary data assets to address strategic challenges. Its focus remains on accelerating innovation and improving patient outcomes through advanced intelligence.
Scorecard: 85.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Sample Quality and Verification | 25 | 9/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 9/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 8/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Data Quality and Fraud Prevention | 10 | 8/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Market Presence | 10 | 10/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 6/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Weighted score | 100 | 85.0 |
Core services
- Clinical Development: Full-service clinical trial solutions and site identification.
- Commercial Analytics: Market access insights and performance benchmarking.
- Information Services: Consulting for pharmacy and wholesaler partners.
Strengths
- Data Depth: Access to vast proprietary databases and non-identified patient records.
- Clinical Expertise: Specialized teams for clinical development and trial management.
- Global Footprint: Unified platforms that support multi-country research and strategy.
Innovation and technology
- IQVIA.ai: Unified agentic platforms for predictive analytics and clinical development.
- Asset Maximizer: Intelligent tools designed to optimize the value of pharmaceutical assets.
Impact on businesses
- Faster Decision Making: Reduces risk and accelerates the delivery of therapies to market.
- Performance Heightening: Increases efficiencies in clinical and commercial operations.
Why it may fit your brief
IQVIA is best suited for large-scale, data-intensive projects. For smaller, rapid-response qualitative studies, a smaller, more agile fieldwork agency might be more efficient.
M3 Global Research: best for high-volume quantitative HCP studies

Strongest fitPharma companies needing rapid, high-volume quantitative data from verified physicians.
M3 Global Research is a dedicated healthcare fieldwork provider that maintains one of the world’s largest proprietary panels of verified professionals. Its presence in Poland is supported by a global infrastructure designed to deliver solid quantitative and qualitative research.
The company places a high priority on compliance and information security, holding multiple ISO certifications. Its methodology is focused on delivering high-quality, actionable data to improve global patient outcomes.
Scorecard: 85.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Sample Quality and Verification | 25 | 9/10 | m3global.com (1 page reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 9/10 | m3global.com (1 page reviewed), Oct 2026 |
| Target Audience Reach | 15 | 8/10 | m3global.com (1 page reviewed), Oct 2026 |
| Data Quality and Fraud Prevention | 10 | 9/10 | m3global.com (1 page reviewed), Oct 2026 |
| Market Presence | 10 | 8/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | m3global.com (1 page reviewed), Oct 2026 |
| Client Service and Speed | 5 | 8/10 | m3global.com (1 page reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | m3global.com (1 page reviewed), Oct 2026 |
| Weighted score | 100 | 85.0 |
Core services
- Fieldwork Services: Quantitative and qualitative research execution.
- HCP Recruitment: Targeted recruitment from a proprietary, verified panel.
- Remote Methodologies: Full range of remote and in-person data collection.
Strengths
- Verified Panel: Largest proprietary physician panel protecting high-quality data.
- Compliance Focus: ISO 20252 and ISO 27001 certified for data quality and security.
- Global Reach: Capacity to deliver projects in over 70 markets.
Innovation and technology
- Proprietary Panel Platform: Uses industry knowledge and technology to optimize fieldwork.
- Rigorous Training: Makes sure all team members hold relevant industry certifications.
Impact on businesses
- Actionable Insights: Drives research that helps improve patient outcomes globally.
- Service Reliability: Consistently delivers engaged respondents on time.
Why it may fit your brief
M3 is a strong choice for large-scale quantitative work. For hyper-niche, highly qualitative studies, a smaller local boutique might offer more personalized project management.
Global Vox Populi: best for highly targeted, verified HCP recruitment
- ISO 9001
- ISO 20252
- ISO/IEC 27001
- HIPAA compliant

Strongest fitPharmaceutical brand managers and market research directors requiring highly verified, compliant, and target-specific HCP samples.
Global Vox Populi operates as an independent firm specializing in primary market research within the healthcare and pharmaceutical sectors. In Poland, the company maintains a significant proprietary infrastructure, making sure that data collection is managed directly by its own team rather than third-party aggregators.
The firm is known for its technical rigor and commitment to data integrity. By owning its panel assets, it provides a level of control over respondent quality that is required for complex clinical and commercial research projects.
Global Vox Populi panel coverage
All 12 proprietary panels together: 46,023,988 panellists across 199 markets, plus 71,411,997 patient profiles. Source: Global Vox Populi panel records, Oct 2026.
Healthcare professionals panel, in Poland
30,852 panellists
- Primary & General10,736
- Internal Medicine Subspecialties3,544
- Surgical Specialties2,704
- Diagnostic & Laboratory2,366
- Acute, Peri-operative & Critical Care2,094
- Women's & Reproductive Health1,990
Key opinion leader panel, in Poland
3,440 panellists
- Internal Medicine Subspecialties593
- Primary & General513
- Surgical Specialties377
- Diagnostic & Laboratory355
- Acute, Peri-operative & Critical Care280
- Nervous System & Mental Health230
Nurses and allied health panel, in Poland
62,598 panellists
- Registered Nurses23,007
- Advanced Practice Nurses1,134
- Licensed / Practical / Enrolled Nurses3,609
- Nursing Support (Aides / HCAs)1,569
- Midwives2,247
- Pharmacists & Pharmacy Techs3,412
Scorecard: 82.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Sample Quality and Verification | 25 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Compliance, Certifications and Security | 20 | 9/10 | ISO certificates and HIPAA policy, Oct 2026 |
| Target Audience Reach | 15 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Data Quality and Fraud Prevention | 10 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Market Presence | 10 | 2/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Client Service and Speed | 5 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 8/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Weighted score | 100 | 82.5 |
Core services
- HCP Recruitment: Access to healthcare professionals including physicians across 70+ specialties.
- KOL Engagement: Specialized key opinion leader recruitment for high-level strategic insights.
- Nurses and Allied Health: Broad reach to nurses and allied health professionals in clinical settings.
- Qualitative Research: Execution of in-depth interviews and focus groups.
Strengths
- Panel Quality: Proprietary panels are built on rigorous invitation and validation processes, protecting high-quality respondent data.
- Regulatory Compliance: Full adherence to BHBIA guidance for adverse event reporting and HIPAA-compliant handling of sensitive health information.
- Verification Protocols: Rolling validation of professional licenses and registrations makes sure that only verified HCPs participate in studies.
- Data Integrity: Multi-layered quality checks, including identity fingerprinting and bot removal, are applied before any data delivery.
Innovation and technology
- Advanced Quality Scoring: Uses proprietary algorithms to detect straight-lining and identify fraudulent completion patterns in real time.
- Platform Technology: Surveys are hosted on a proprietary, secure platform that supports mobile and WhatsApp-assisted fieldwork.
Impact on businesses
- Decision Support: Delivers accurate insights to inform product launches and commercial strategy for pharmaceutical brands.
- Risk Mitigation: Protects data compliance and accuracy to protect clients during complex regulatory and market access processes.
Why it may fit your brief
The provider is ideal for projects where respondent quality and strict regulatory compliance are the primary concerns. For simple, non-healthcare consumer research, a larger generalist agency might offer broader reach, but for pharma-specific needs, this specialist approach is superior.
Dynata: best for global first-party data access

Strongest fitGlobal brands needing high-volume, verified respondent data across multiple international markets.
Dynata is a global provider of first-party data, connecting researchers with verified professionals and patients. Its presence in Poland is part of a vast international network that protects representativeness and data integrity.
The company focuses on delivering high-quality data through its QualityScore technology. It offers multiple methodologies, including online, telephone, and mobile research, to reach hard-to-access audiences.
Scorecard: 82.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Sample Quality and Verification | 25 | 9/10 | dynata.com (4 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 9/10 | dynata.com (4 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 8/10 | dynata.com (4 pages reviewed), Oct 2026 |
| Data Quality and Fraud Prevention | 10 | 9/10 | dynata.com (4 pages reviewed), Oct 2026 |
| Market Presence | 10 | 5/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | dynata.com (4 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 8/10 | dynata.com (4 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | dynata.com (4 pages reviewed), Oct 2026 |
| Weighted score | 100 | 82.0 |
Core services
- First-Party Data: Access to millions of deeply profiled panelists globally.
- Methodological Design: Expert support for designing complex research methodologies.
- Brand Lift Studies: Measuring the impact of advertising on brand perception.
Strengths
- QualityScore Technology: Uses machine learning to identify fraud and inattention.
- Extensive Reach: Access to 70M+ global panelists for diverse sampling needs.
- Flexibility: Offers both self-service and fully managed service models.
Innovation and technology
- Dynata+: Research-grade data platform for real-time feasibility and launch.
- Conversational AI: Uses AI to probe open-ended survey answers at scale.
Impact on businesses
- Effective Targeting: Helps brands refine plans and optimize customer touchpoints.
- Smarter Decisions: Drives business growth through high-quality data and insights.
Why it may fit your brief
Dynata is excellent for global scale. For projects requiring highly localized, boutique-style qualitative management in Poland, a local specialist might be better.
Kantar: best for brand growth and human understanding

Strongest fitMarketing teams needing brand health tracking and consumer-oriented market research.
Kantar uses its global reach and proprietary technology to deliver deep insights into human behavior. In Poland, the firm provides custom survey research and strategic consulting, focusing on brand equity and consumer understanding.
The company emphasizes quality through its Qubed AI platform, which aims to detect fraud and improve respondent data. Its services span from brand valuation to complex quantitative survey design.
Scorecard: 80.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Sample Quality and Verification | 25 | 8/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 8/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 7/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Data Quality and Fraud Prevention | 10 | 9/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Market Presence | 10 | 10/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Weighted score | 100 | 80.5 |
Core services
- Brand Strategy: Established brand valuation and equity studies.
- Custom Surveys: Expertly designed quantitative research services.
- Audience Activation: Digital targeting and audience validation solutions.
Strengths
- Data Quality: Proprietary AI technology to identify fraudulent activity.
- Global Scale: Extensive panel network across over 100 markets.
- Expert Design: Experienced teams assisting in complex survey design.
Innovation and technology
- Qubed AI: Next-generation tech to detect fraud in milliseconds.
- Kantar Marketplace: Platform combining agile products with powerful analytics.
Impact on businesses
- Brand Growth: Helps organizations make data-driven decisions to build strong brands.
- ROI Optimization: Protects creative and effective ads drive profitability.
Why it may fit your brief
Kantar excels in consumer and brand research. For highly specialized clinical or medical-only research, a firm with a dedicated, verified medical panel might be more appropriate.
Ipsos: best for large-scale representative studies

Strongest fitOrganizations requiring large-scale, representative public opinion or healthcare system research.
Ipsos is a major global research company with a physical presence in Poland, specializing in understanding society, markets, and people. It delivers insights across various sectors, including dedicated health service reporting.
The company combines survey data with social media and qualitative methods to provide comprehensive views of patient and professional attitudes. Its focus is on providing reliable information to help clients make better, faster decisions.
Scorecard: 79.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Sample Quality and Verification | 25 | 8/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 8/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 7/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Data Quality and Fraud Prevention | 10 | 8/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Market Presence | 10 | 10/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 6/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Weighted score | 100 | 79.0 |
Core services
- Health Service Reports: Tracking perceptions of healthcare quality and systems.
- Brand Health Tracking: Ongoing monitoring of brand performance and sentiment.
- Qualitative Research: In-depth understanding through communities and qualitative design.
Strengths
- Global Trends: Deep expertise in tracking large-scale societal and market trends.
- Methodological Breadth: Combines surveys with social media and qualitative analysis.
- Actionable Truth: Focus on turning data into insights for better business decisions.
Innovation and technology
- AI Integration: Uses AI to deliver insights and analyze complex data sources.
- Augmented Ipsos: New corporate initiatives to enhance research delivery.
Impact on businesses
- Smarter Decisions: Helps clients act faster and more consistently across markets.
- True Understanding: Provides meaningful context to societal and market phenomena.
Why it may fit your brief
Ipsos is ideal for broad, representative studies. For highly targeted, low-incidence HCP research, a specialized panel provider may offer more precise access.
Stratega Poland: best for local fieldwork and CATI services

Strongest fitAgencies needing a reliable local fieldwork partner for qualitative and quantitative projects in Poland.
Stratega Poland functions as a full-service agency with deep local expertise in Poland and surrounding Eastern European markets. It operates an in-house medical panel and a CATI center, making it a strong partner for complex local data collection.
The company supports international research agencies by providing high-quality fieldwork, including focus groups, interviews, and quantitative recruitment. Its focus is on professional execution and transparent reporting.
Scorecard: 78.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Sample Quality and Verification | 25 | 8/10 | strategaresearch.com (6 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 8/10 | strategaresearch.com (6 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 8/10 | strategaresearch.com (6 pages reviewed), Oct 2026 |
| Data Quality and Fraud Prevention | 10 | 7/10 | strategaresearch.com (6 pages reviewed), Oct 2026 |
| Market Presence | 10 | 6/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 9/10 | strategaresearch.com (6 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 8/10 | strategaresearch.com (6 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 8/10 | strategaresearch.com (6 pages reviewed), Oct 2026 |
| Weighted score | 100 | 78.0 |
Core services
- Fieldwork Execution: Recruitment, moderation, and data collection services.
- CATI Services: Dedicated telephone interview infrastructure.
- Qualitative Facilities: Viewing facilities for focus groups and IDIs.
Strengths
- Local Expertise: Established recruiter networks across Poland and Eastern Europe.
- Panel Size: Healthcare panel of over 17,000 verified professionals.
- Methodological Flexibility: Combines traditional and innovative techniques for data collection.
Innovation and technology
- Quality Systems: Strict validation procedures for all healthcare professionals.
- Reporting Tools: Provides summary reports and competitive analysis in English.
Impact on businesses
- Decision Support: Supports investment and commercial decisions for clients.
- Operational Efficiency: Delivers tailored proposals and reliable data collection.
Why it may fit your brief
Stratega is ideal for locally executed fieldwork. For projects requiring massive global reach beyond Eastern Europe, a larger international network might be more suitable.
BioStat: best for clinical and statistical research

Strongest fitPharma companies requiring clinical data management alongside market research.
BioStat is an R&D center in Poland that bridges the gap between clinical research and market analysis. It provides comprehensive CRO services, data management, and specialized healthcare market research.
The company uses its technical expertise in medicine and statistics to offer high-quality data collection. Its services are used by both commercial pharmaceutical firms and academic institutions.
Scorecard: 75.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Sample Quality and Verification | 25 | 8/10 | biostat.com.pl (3 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 8/10 | biostat.com.pl (3 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 7/10 | biostat.com.pl (3 pages reviewed), Oct 2026 |
| Data Quality and Fraud Prevention | 10 | 8/10 | biostat.com.pl (3 pages reviewed), Oct 2026 |
| Market Presence | 10 | 6/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | biostat.com.pl (3 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | biostat.com.pl (3 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | biostat.com.pl (3 pages reviewed), Oct 2026 |
| Weighted score | 100 | 75.5 |
Core services
- CRO Services: Comprehensive support for clinical trials and research.
- Medical Statistics: Advanced statistical analysis for medical data.
- Market Research: Specialized opinions and mystery shopping for pharma.
Strengths
- Technical Expertise: Strong background in medical and statistical science.
- Data Reliability: Rigorous approach to data management and validation.
- Panel Reach: Access to over 200,000 respondents for diverse studies.
Innovation and technology
- Mobile Solutions: Allows surveys to be completed on smartphones and tablets.
- Multimedial Surveys: Integrates audio-visual materials into the research process.
Impact on businesses
- Business Direction: Provides solutions that indicate clear directions for business decisions.
- Product Development: Helps in the development of products through reliable market research.
Why it may fit your brief
BioStat is unique due to its clinical trial roots. For pure consumer-style brand research, a more marketing-focused agency might be more appropriate.
ARC Rynek i Opinia: best for independent Polish market tracking

Strongest fitCompanies needing long-term tracking and independent market insights in Poland.
ARC Rynek i Opinia is a well-established Polish research institute with over 30 years of experience. It specializes in providing independent market insights across various sectors, including pharmaceuticals and medical services.
The company maintains a large proprietary consumer panel, ePanel.pl, and solid CATI infrastructure. Its approach is built on maintaining intellectual independence and understanding real-world consumer behaviors.
Scorecard: 68.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Sample Quality and Verification | 25 | 7/10 | arc.com.pl (5 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 7/10 | arc.com.pl (5 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 6/10 | arc.com.pl (5 pages reviewed), Oct 2026 |
| Data Quality and Fraud Prevention | 10 | 7/10 | arc.com.pl (5 pages reviewed), Oct 2026 |
| Market Presence | 10 | 6/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | arc.com.pl (5 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | arc.com.pl (5 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 6/10 | arc.com.pl (5 pages reviewed), Oct 2026 |
| Weighted score | 100 | 68.0 |
Core services
- Market Tracking: Long-term monitoring of market trends and phenomena.
- Data Collection: Extensive CATI and CAWI infrastructure.
- Analytical Services: Expert knowledge supporting planning and development.
Strengths
- Market Experience: Over 33 years of presence in the Polish market.
- Infrastructure: Large-scale CATI facility and proprietary online panel.
- Independence: Focus on intellectual independence and objective insights.
Innovation and technology
- Mobile Engagement: Mobile-first survey design and dedicated panel application.
- Cint Integration: Uses advanced CAWI research software solutions.
Impact on businesses
- Risk Reduction: Helps clients avoid missing consumer needs and tastes.
- Strategic Support: Provides essential information for planning and development.
Why it may fit your brief
ARC is a strong choice for general market tracking. For highly specialized pharma research, a more medical-centric panel provider might be more effective.
Toluna: best for rapid consumer and patient insights

Strongest fitCompanies needing fast, consumer-oriented feedback to guide rapid tactical decisions.
Toluna is a global leader in technology-driven market research, providing on-demand consumer insights. It maintains a proprietary panel and uses AI to deliver data to brands and agencies quickly.
The company supports healthcare research by providing access to medical professionals and patients. Its focus is on allowing companies to influence product development through real-time feedback.
Scorecard: 67.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Sample Quality and Verification | 25 | 7/10 | toluna.com (2 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 7/10 | toluna.com (2 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 6/10 | toluna.com (2 pages reviewed), Oct 2026 |
| Data Quality and Fraud Prevention | 10 | 8/10 | toluna.com (2 pages reviewed), Oct 2026 |
| Market Presence | 10 | 5/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 7/10 | toluna.com (2 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | toluna.com (2 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 6/10 | toluna.com (2 pages reviewed), Oct 2026 |
| Weighted score | 100 | 67.0 |
Core services
- On-Demand Insights: Real-time connection between businesses and consumers.
- Panel Access: Access to a global community for market research surveys.
- Technology Platform: AI-powered tools for survey programming and data analysis.
Strengths
- Speed: Enables rapid data collection for time-sensitive projects.
- Community Engagement: Large, active community of influencers and respondents.
- Technology: Advanced AI tools to simplify the research process.
Innovation and technology
- Influence Your World: Community-based engagement model for real-time feedback.
- Real-time Analytics: Provides immediate insights to inform decision-making.
Impact on businesses
- Change Inspiration: Helps brands shape their products and services in real time.
- Market Pulse: Keeps clients informed of current consumer trends.
Why it may fit your brief
Toluna is best for speed and consumer reach. For deeply specialized clinical or regulatory research, a pharma-focused specialist provider would be more effective.
How HCP credential verification actually works in Poland
Action title: Mandate multi-point license verification for all healthcare professional participants.
Professional Credential Auditing
The foundation of reliable pharmaceutical research is the verified status of the respondent. A provider must perform a primary source verification of medical registration against official Polish medical chamber databases. Ask the provider for proof of their re-validation cycle, which should happen at least annually. If a provider cannot demonstrate how they confirm that a doctor is currently practicing in the specific requested specialty, the risk of non-professional participation is high. Request a sample verification report to understand the audit trail they maintain for every panelist recruited.
Identity and Fraud Detection
Beyond medical credentials, identity verification is essential. Good practice involves device fingerprinting and IP address location checks to make sure the participant is physically located in Poland. Protect the provider uses trap questions and straight-lining detection to identify respondents who are not paying attention. Ask about their de-duplication strategy; a high-quality firm will prevent the same individual from participating in multiple surveys for the same client. These measures are the minimum standard for protecting the integrity of pharmaceutical study results.
Adverse Event Reporting
For pharma research, verification extends to safety protocols. Any provider working with HCPs in Poland must have a clear, documented process for identifying and reporting adverse events or product complaints. Ask to see their standard operating procedure for handling this. If they do not have a defined BHBIA or similar industry-standard reporting flow, they are not suited for medical research. The provider must be able to demonstrate that their staff is trained to flag these events immediately to the client.
Data Protection Compliance
Finally, verify that the provider follows GDPR and local Polish law regarding the processing of sensitive health data. The provider should offer granular, revocable consent forms that explain exactly how the HCP's information will be used. Make sure they have clear data security certifications like ISO/IEC 27001 in place. A failure here is not just a research problem; it is a significant legal and reputational risk for the pharmaceutical company commissioning the work.
How to choose the right provider in Poland
Action title: Use a structured checklist to evaluate panel providers before commissioning pharmaceutical research.
- Verify panel ownership: Prioritize providers that own their HCP panels. Third-party aggregators often have less control over verification quality and consistency.
- Check compliance standards: Make sure the provider has documented procedures for adverse event reporting. This is a non-negotiable requirement for all pharma-related research.
- Assess specialty depth: Request a feasibility check for your specific medical specialty. A high-quality provider will provide realistic numbers based on their actual database.
- Review verification process: Ask for a detailed explanation of how they verify medical licenses. If they cannot produce a clear process, exclude them from your shortlist.
- Evaluate data controls: Confirm the provider uses automated tools for fraud detection. Manual checks are rarely sufficient for high-volume online studies.
Questions to ask before you commission
- Can you provide a detailed description of your HCP license verification process for Poland?
- How do you handle adverse event reporting, and can you share your standard operating procedure?
- What specific technologies do you use to detect fraud and straight-lining in your surveys?
- Are you able to provide a feasibility estimate for my target specialty within 24 hours?
- What is your re-validation cycle for making sure that your HCP panelist data remains accurate?
- Can you demonstrate your compliance with GDPR and local Polish data protection requirements?
Common pitfalls to avoid
- Using open sample exchanges: Relying on generic sample exchanges for medical research often leads to poor data quality and non-verified respondents.
- Ignoring adverse event protocols: Failing to establish a clear reporting flow for adverse events can lead to significant regulatory and legal issues.
- Overestimating panel capacity: Assuming a large consumer panel translates to access to niche medical specialists without a feasibility check.
- Neglecting license re-validation: Assuming a respondent is still a practicing physician based on outdated profile data rather than current registration.
What a feasibility check should include
Action title: Require a written feasibility report that breaks down specific target audience availability before starting.
Define target criteria
Provide the exact specialty, sub-specialty, and any professional experience criteria. This makes sure the provider is searching for the correct profile.
Request panel counts
Ask for the number of active, verified panelists matching your criteria. A good provider will be transparent about the actual reach.
Confirm recruitment sources
Understand where the respondents originate, such as professional associations or medical registries. This confirms the quality of the audience.
Assess project timeline
Ask for a realistic estimate of how long recruitment will take. Be wary of providers that promise unrealistic timelines for rare specialties.
Conclusion
Selecting the right partner for pharmaceutical research in Poland is a critical decision that influences the reliability of your strategic outputs. For complex, highly targeted projects, prioritize firms with dedicated, verified medical panels that provide clear visibility into their recruitment and verification processes.
Use the provided scorecard to compare potential partners based on your specific study needs. If your project demands high-volume, rapid quantitative data, large-scale agencies with global infrastructures are suitable. Conversely, for deep-dive qualitative studies or niche clinical requirements, boutique specialists often offer superior precision and transparency. Always conduct a feasibility check and request evidence of their compliance protocols before finalizing your selection to make sure your research meets all legal and regulatory standards.
Planning research in Poland? Tell us your audience, markets and timeline, and we will come back with a feasibility check and recommended approach.
Frequently asked questions
What are the top healthcare market research companies in Poland?
The market includes several capable firms. Global Vox Populi, IQVIA, Stratega, M3 Global Research, and Ipsos are recognized for their healthcare research capabilities. Your choice should depend on whether you need large-scale global data or highly specialized, verified local HCP recruitment.
How do I recruit healthcare professionals for market research in Poland?
Recruitment should be conducted through proprietary, verified medical panels. Avoid using open consumer sample exchanges. The most reliable method involves inviting professionals through medical registries, professional associations, and verified CME communities to make sure the participants are active, licensed practitioners.
Does IQVIA have healthcare panels in Poland?
Yes, IQVIA maintains an extensive presence in Poland and uses its global healthcare data and analytics infrastructure to provide research solutions. It is known for its ability to integrate real-world data with commercial insights for pharmaceutical and biotech clients.
Which market research agencies in Poland specialize in pharma?
Several agencies offer specialized pharma research. Global Vox Populi and Stratega are known for their focused healthcare panels and local fieldwork control. IQVIA and M3 Global Research provide broader global infrastructure tailored to the needs of the life sciences sector.
What is the best online panel for HCP research in Poland?
There is no single best panel; the right choice depends on your requirements. Global Vox Populi and M3 Global Research are recognized for their proprietary and verified HCP panels. Assess each provider based on their verification protocols and their ability to reach your specific medical specialty.
How do I conduct medical market research in Poland?
Conducting medical research requires strict adherence to regulatory standards like GDPR and BHBIA guidelines. You should work with a provider that manages the entire lifecycle, including compliant recruitment, verified data collection, and established protocols for adverse event reporting.
Are there global HCP panels that cover Poland?
Yes, several global providers like Dynata, M3 Global Research, and Ipsos maintain international networks that include Poland. These global panels are often useful for multi-country studies that require consistent data collection and standardized methodology across different regional markets.
Why is local panel control important for pharma research?
Local control makes sure that the provider understands the specific medical environment and regulatory requirements in Poland. It allows for more rigorous verification of professional licenses and makes sure that the recruitment process is compliant with local laws, reducing the risk of poor-quality data.